🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Liana Nikolaenko

City Of Hope National Medical Center

ORCID: 0000-0003-0542-1712

Also affiliated with City of Hope, Gilead Sciences (Australia), Kite (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE”.

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood(2022)10.1182/blood.2022015423

N/A

3.0DataRank · unranked

121 citations

Hun Ju Lee, Joycelynne Palmer, Robert Chen, Ni‐Chun Tsai, Lu Chen +18 more

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood(2023)10.1182/blood.2023020485

N/A

1.3DataRank · unranked

40 citations

Lu Chen, James Godfrey, Joo Y. Song, Colt A. Egelston, Sandrine Puverel +18 more

Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma

Haematologica(2023)10.3324/haematol.2023.283002

N/A

0.599DataRank · unranked

19 citations

Matthew Mei, Lu Chen, Joo Y. Song, Victoria Bedell, Elizabeth Budde +13 more

Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

American Journal of Hematology(2023)10.1002/ajh.26824

N/A

0.429DataRank · unranked

11 citations

Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze +11 more

Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.01.010

N/A

0DataRank · unranked

15 citations

Saurabh Chhabra, Noa Biran, Arnab Chowdhury, Parameswaran Hari, Amrita Krishnan +2 more

143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)

Hematological Oncology(2025)10.1002/hon.70093_143

N/A

0DataRank · unranked

1 citations

Constance Lau, Mazyar Shadman, Alex F. Herrera, Caron A. Jacobson, F. L. Locke +13 more

Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program

Cancer Causes & Control(2022)10.1007/s10552-022-01619-1

N/A

0DataRank · unranked

7 citations

Kimlin Ashing, Sophia Yeung, Jonjon Macalintal, Brian Tiep, Argelia Sandoval +24 more

Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

American Journal of Hematology(2023)10.1002/ajh.27069

N/A

0DataRank · unranked

34 citations

Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H. Baird +13 more

Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7100

N/A

0DataRank · unranked

12 citations

Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh +17 more